EP2097572A2 - Textilien- und/oder faserverarbeitungsverfahren unter verwendung eines aus nanopartikeln zusammengesetzten wirkstoff-bestandteils - Google Patents
Textilien- und/oder faserverarbeitungsverfahren unter verwendung eines aus nanopartikeln zusammengesetzten wirkstoff-bestandteilsInfo
- Publication number
- EP2097572A2 EP2097572A2 EP07870285A EP07870285A EP2097572A2 EP 2097572 A2 EP2097572 A2 EP 2097572A2 EP 07870285 A EP07870285 A EP 07870285A EP 07870285 A EP07870285 A EP 07870285A EP 2097572 A2 EP2097572 A2 EP 2097572A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- textile
- nanoparticles
- active ingredient
- fibers
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000004753 textile Substances 0.000 title claims abstract description 82
- 239000004480 active ingredient Substances 0.000 title claims abstract description 40
- 239000000835 fiber Substances 0.000 title claims abstract description 33
- 239000002105 nanoparticle Substances 0.000 title claims abstract description 29
- 238000003672 processing method Methods 0.000 title 1
- 238000005507 spraying Methods 0.000 claims abstract description 8
- 239000007864 aqueous solution Substances 0.000 claims abstract description 6
- 238000000034 method Methods 0.000 claims description 37
- 238000005470 impregnation Methods 0.000 claims description 17
- 239000002537 cosmetic Substances 0.000 claims description 9
- -1 stylbens Chemical class 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 239000000839 emulsion Substances 0.000 claims description 6
- 239000007908 nanoemulsion Substances 0.000 claims description 6
- 238000007598 dipping method Methods 0.000 claims description 5
- 239000011782 vitamin Substances 0.000 claims description 5
- 235000013343 vitamin Nutrition 0.000 claims description 5
- 229940088594 vitamin Drugs 0.000 claims description 5
- 229930003231 vitamin Natural products 0.000 claims description 5
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 4
- 239000000341 volatile oil Substances 0.000 claims description 4
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 claims description 3
- 229940088710 antibiotic agent Drugs 0.000 claims description 3
- ZGGHKIMDNBDHJB-NRFPMOEYSA-M (3R,5S)-fluvastatin sodium Chemical compound [Na+].C12=CC=CC=C2N(C(C)C)C(\C=C\[C@@H](O)C[C@@H](O)CC([O-])=O)=C1C1=CC=C(F)C=C1 ZGGHKIMDNBDHJB-NRFPMOEYSA-M 0.000 claims description 2
- METKIMKYRPQLGS-GFCCVEGCSA-N (R)-atenolol Chemical compound CC(C)NC[C@@H](O)COC1=CC=C(CC(N)=O)C=C1 METKIMKYRPQLGS-GFCCVEGCSA-N 0.000 claims description 2
- SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 claims description 2
- XMWRBQBLMFGWIX-UHFFFAOYSA-N C60 fullerene Chemical class C12=C3C(C4=C56)=C7C8=C5C5=C9C%10=C6C6=C4C1=C1C4=C6C6=C%10C%10=C9C9=C%11C5=C8C5=C8C7=C3C3=C7C2=C1C1=C2C4=C6C4=C%10C6=C9C9=C%11C5=C5C8=C3C3=C7C1=C1C2=C4C6=C2C9=C5C3=C12 XMWRBQBLMFGWIX-UHFFFAOYSA-N 0.000 claims description 2
- IIUZTXTZRGLYTI-UHFFFAOYSA-N Dihydrogriseofulvin Natural products COC1CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 IIUZTXTZRGLYTI-UHFFFAOYSA-N 0.000 claims description 2
- UXWOXTQWVMFRSE-UHFFFAOYSA-N Griseoviridin Natural products O=C1OC(C)CC=C(C(NCC=CC=CC(O)CC(O)C2)=O)SCC1NC(=O)C1=COC2=N1 UXWOXTQWVMFRSE-UHFFFAOYSA-N 0.000 claims description 2
- DDUHZTYCFQRHIY-UHFFFAOYSA-N Negwer: 6874 Natural products COC1=CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-UHFFFAOYSA-N 0.000 claims description 2
- 150000001413 amino acids Chemical class 0.000 claims description 2
- 239000003242 anti bacterial agent Substances 0.000 claims description 2
- 230000003266 anti-allergic effect Effects 0.000 claims description 2
- 230000001857 anti-mycotic effect Effects 0.000 claims description 2
- 239000002543 antimycotic Substances 0.000 claims description 2
- 239000002249 anxiolytic agent Substances 0.000 claims description 2
- 230000000949 anxiolytic effect Effects 0.000 claims description 2
- 229940005530 anxiolytics Drugs 0.000 claims description 2
- 229960002274 atenolol Drugs 0.000 claims description 2
- 150000001765 catechin Chemical class 0.000 claims description 2
- 235000005487 catechin Nutrition 0.000 claims description 2
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 claims description 2
- 239000003433 contraceptive agent Substances 0.000 claims description 2
- 229940124558 contraceptive agent Drugs 0.000 claims description 2
- 239000000824 cytostatic agent Substances 0.000 claims description 2
- 239000000796 flavoring agent Substances 0.000 claims description 2
- 235000019634 flavors Nutrition 0.000 claims description 2
- 229960003765 fluvastatin Drugs 0.000 claims description 2
- 229910003472 fullerene Inorganic materials 0.000 claims description 2
- DDUHZTYCFQRHIY-RBHXEPJQSA-N griseofulvin Chemical compound COC1=CC(=O)C[C@@H](C)[C@@]11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-RBHXEPJQSA-N 0.000 claims description 2
- 229960002867 griseofulvin Drugs 0.000 claims description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 2
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 claims description 2
- 229960000991 ketoprofen Drugs 0.000 claims description 2
- 239000011707 mineral Substances 0.000 claims description 2
- 235000010755 mineral Nutrition 0.000 claims description 2
- 239000002088 nanocapsule Substances 0.000 claims description 2
- 239000002077 nanosphere Substances 0.000 claims description 2
- 239000000813 peptide hormone Substances 0.000 claims description 2
- 229920005862 polyol Polymers 0.000 claims description 2
- 150000003077 polyols Chemical class 0.000 claims description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 2
- 235000013824 polyphenols Nutrition 0.000 claims description 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- 229960000620 ranitidine Drugs 0.000 claims description 2
- VMXUWOKSQNHOCA-LCYFTJDESA-N ranitidine Chemical compound [O-][N+](=O)/C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 VMXUWOKSQNHOCA-LCYFTJDESA-N 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 239000000932 sedative agent Substances 0.000 claims description 2
- 229940125723 sedative agent Drugs 0.000 claims description 2
- 230000001225 therapeutic effect Effects 0.000 claims description 2
- 239000004408 titanium dioxide Substances 0.000 claims description 2
- 239000011573 trace mineral Substances 0.000 claims description 2
- 235000013619 trace mineral Nutrition 0.000 claims description 2
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 claims description 2
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 claims description 2
- 235000012141 vanillin Nutrition 0.000 claims description 2
- 229960001722 verapamil Drugs 0.000 claims description 2
- 239000011787 zinc oxide Substances 0.000 claims description 2
- 229940126575 aminoglycoside Drugs 0.000 claims 1
- 230000000887 hydrating effect Effects 0.000 claims 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 claims 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 claims 1
- 239000002159 nanocrystal Substances 0.000 claims 1
- 239000004745 nonwoven fabric Substances 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 238000002791 soaking Methods 0.000 abstract description 10
- 150000001875 compounds Chemical class 0.000 abstract description 5
- 239000000975 dye Substances 0.000 description 16
- 239000004744 fabric Substances 0.000 description 10
- 239000000243 solution Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 238000005406 washing Methods 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000003094 microcapsule Substances 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 3
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 238000002845 discoloration Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229940041616 menthol Drugs 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000002917 insecticide Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- 239000012209 synthetic fiber Substances 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- JETQIUPBHQNHNZ-NJBDSQKTSA-N (2s,5r,6r)-3,3-dimethyl-7-oxo-6-[[(2r)-2-phenyl-2-sulfoacetyl]amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid Chemical compound C1([C@H](C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)S(O)(=O)=O)=CC=CC=C1 JETQIUPBHQNHNZ-NJBDSQKTSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- QYQDKDWGWDOFFU-IUODEOHRSA-N Cefotiam Chemical compound CN(C)CCN1N=NN=C1SCC1=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CC=3N=C(N)SC=3)[C@H]2SC1 QYQDKDWGWDOFFU-IUODEOHRSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 240000000491 Corchorus aestuans Species 0.000 description 1
- 235000011777 Corchorus aestuans Nutrition 0.000 description 1
- 235000010862 Corchorus capsularis Nutrition 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 244000178870 Lavandula angustifolia Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 108010000817 Leuprolide Proteins 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- NCYCYZXNIZJOKI-OVSJKPMPSA-N Retinaldehyde Chemical compound O=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-OVSJKPMPSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 229920002334 Spandex Polymers 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 101800004623 Thyrotropin-releasing hormone Proteins 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000000895 acaricidal effect Effects 0.000 description 1
- 239000000642 acaricide Substances 0.000 description 1
- 229920005822 acrylic binder Polymers 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000002216 antistatic agent Substances 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- HJJDBAOLQAWBMH-YCRCPZNHSA-N cefmenoxime Chemical compound S([C@@H]1[C@@H](C(N1C=1C(O)=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1CSC1=NN=NN1C HJJDBAOLQAWBMH-YCRCPZNHSA-N 0.000 description 1
- 229960003791 cefmenoxime Drugs 0.000 description 1
- 229960001242 cefotiam Drugs 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 230000001085 cytostatic effect Effects 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000007720 emulsion polymerization reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000003063 flame retardant Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 235000004554 glutamine Nutrition 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 239000013003 healing agent Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229930013032 isoflavonoid Natural products 0.000 description 1
- 150000003817 isoflavonoid derivatives Chemical class 0.000 description 1
- 235000012891 isoflavonoids Nutrition 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- GFIJNRVAKGFPGQ-LIJARHBVSA-N leuprolide Chemical compound CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)CC1=CC=C(O)C=C1 GFIJNRVAKGFPGQ-LIJARHBVSA-N 0.000 description 1
- 229960004338 leuprorelin Drugs 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 150000002826 nitrites Chemical class 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- XNSAINXGIQZQOO-SRVKXCTJSA-N protirelin Chemical compound NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H]1NC(=O)CC1)CC1=CN=CN1 XNSAINXGIQZQOO-SRVKXCTJSA-N 0.000 description 1
- 239000002096 quantum dot Substances 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 235000020945 retinal Nutrition 0.000 description 1
- 239000011604 retinal Substances 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 229960004932 sulbenicillin Drugs 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 229940034199 thyrotropin-releasing hormone Drugs 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- GPPXJZIENCGNKB-UHFFFAOYSA-N vanadium Chemical compound [V]#[V] GPPXJZIENCGNKB-UHFFFAOYSA-N 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- 150000003952 β-lactams Chemical class 0.000 description 1
Classifications
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M23/00—Treatment of fibres, threads, yarns, fabrics or fibrous goods made from such materials, characterised by the process
- D06M23/08—Processes in which the treating agent is applied in powder or granular form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/11—Encapsulated compositions
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M13/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment
- D06M13/005—Compositions containing perfumes; Compositions containing deodorants
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M23/00—Treatment of fibres, threads, yarns, fabrics or fibrous goods made from such materials, characterised by the process
- D06M23/06—Processes in which the treating agent is dispersed in a gas, e.g. aerosols
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06P—DYEING OR PRINTING TEXTILES; DYEING LEATHER, FURS OR SOLID MACROMOLECULAR SUBSTANCES IN ANY FORM
- D06P1/00—General processes of dyeing or printing textiles, or general processes of dyeing leather, furs, or solid macromolecular substances in any form, classified according to the dyes, pigments, or auxiliary substances employed
- D06P1/0004—General aspects of dyeing
- D06P1/0016—Dye baths containing a dyeing agent in a special form such as for instance in melted or solid form, as a floating film or gel, spray or aerosol, or atomised dyes
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06P—DYEING OR PRINTING TEXTILES; DYEING LEATHER, FURS OR SOLID MACROMOLECULAR SUBSTANCES IN ANY FORM
- D06P1/00—General processes of dyeing or printing textiles, or general processes of dyeing leather, furs, or solid macromolecular substances in any form, classified according to the dyes, pigments, or auxiliary substances employed
- D06P1/0032—Determining dye recipes and dyeing parameters; Colour matching or monitoring
-
- G—PHYSICS
- G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
- G09F—DISPLAYING; ADVERTISING; SIGNS; LABELS OR NAME-PLATES; SEALS
- G09F3/00—Labels, tag tickets, or similar identification or indication means; Seals; Postage or like stamps
- G09F3/02—Forms or constructions
-
- G—PHYSICS
- G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
- G09F—DISPLAYING; ADVERTISING; SIGNS; LABELS OR NAME-PLATES; SEALS
- G09F3/00—Labels, tag tickets, or similar identification or indication means; Seals; Postage or like stamps
- G09F3/02—Forms or constructions
- G09F3/0291—Labels or tickets undergoing a change under particular conditions, e.g. heat, radiation, passage of time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/413—Nanosized, i.e. having sizes below 100 nm
Definitions
- the present invention relates to the treatment of a textile and / or fibers for the manufacture of a textile, for the purpose of administering to a subject at least one pharmaceutical or cosmetic active principle by contact between the textile and the textile. skin of the subject.
- Grafting techniques are known which, if they make it possible to control the problems of exhaustion and resistance to washing, prohibit any reloading by the consumer, since these grafting techniques require reagents and conditions for treating the fibers and / or textiles that can not be implemented by the end user.
- this type of fixation underlies that the active ingredients are fixed durably, which is not appropriate for cosmeto-textiles, since it is sought, in this technical field, to release easily active principles.
- impregnation techniques are conventionally used for the treatment of fibers and / or textiles to permanently fix additives such as dyes and dyes that are not intended to be salted out.
- US 2005/0132500 A1 describes insecticidal compositions in solid or aqueous forms, comprising an insecticide and an acrylic binder, obtained by emulsion polymerization, and intended to impregnate fibers and / or textiles and / or plastic materials.
- FR 2838459 A1 textile materials in the field of clothing or furniture impregnated by the so-called ionization recoil process for reloading the active ingredient after washing, said active ingredient being applied by spraying, after preheating in a humidified atmosphere saturated with water and application of one or more substances in solution or dispersion after addition of a binding agent or adhesion agent.
- This technique makes it possible to fix active ingredients for a duration equal to at least three days.
- microencapsulated textile technique allows the attachment of active ingredients by fixing microcapsules on the textile.
- the microcapsules are indeed individualized microparticles consisting of a coating polymeric material containing an active ingredient.
- the size of a microcapsule is between 1 ⁇ m and 1 mm. The capsule will allow the release of the active ingredient by rupture, for example by friction of the envelope or by slow diffusion through the membrane whose porosity will change over time.
- microencapsulation technique requires the use of a binder to fix the microcapsules on the fibers and / or textiles, and this because of their low affinity for them; their voluminous size, making insertion into the heart of the fibers difficult, only leads to impregnation on the surface.
- this microencapsulation technique requires the presence of polymeric capsules, which will accumulate in the textile and cause a phenomenon of fiber poisoning, as well as possible problems of intolerance, if these microcapsules are used to provide active ingredients on the skin.
- the present invention therefore relates to a process for treating a textile and / or fibers for the manufacture of a textile, said textile being intended for administration to a subject of at least one pharmaceutical or cosmetic active principle by contact between said textile and the skin of the subject characterized in that:
- At least one active ingredient in the form of nanoparticles is available in an aqueous solution, said textile is impregnated with
- the present invention also relates to a textile and / or fibers impregnated with at least one cosmetic or pharmaceutical active ingredient that can be obtained by the process for treating a textile and / or fibers according to the invention.
- the invention also relates to a method of non-therapeutic administration of at least one cosmetic active ingredient to and / or in the skin of a subject carrying a textile impregnated with said at least one cosmetic active ingredient in the form of nanoparticles.
- the nanoparticles are particles whose size is less than 300 nm (0.3 ⁇ m), and an average of 150 nm.
- nanoparticles that can be used in the present invention, there may be mentioned titanium dioxide, zinc oxide, fullerenes, nanochstals (also called “quantum dots”, namely semiconductor crystals), as well as nanoemulsions, nanocapsules, nanospheres, nanovesicles or spherulites.
- nanoparticles in the form of nanoemulsion they can be obtained by any method known to those skilled in the art for producing emulsions. In this respect, one can reference the dosage works such as "Pharmaceutical Technology", A. Le Hir, Editions Masson (8 lem edition 2006).
- nanoparticles can also be obtained by the processes described in patent applications EP 0 717 989 A1, WO 2000/71676 A1, WO 2001/64328 A1 and WO 2004/060358 A2.
- Patent application WO2004 / 060358 A2 indeed describes a process for preparing PIT emulsion.
- the active ingredients are chosen from pharmaceutical or cosmetic active ingredients.
- the active ingredients may be chosen from slimming, cooling or moisturizing active ingredients.
- the active ingredients are lipophilic or hydrophilic.
- Lipophilic active principles include:
- liposoluble vitamins and their derivatives such as the family of retinoids, for example retinol, retinaldehyde, retinoic acid, carotenoids, tocopherol and its derivatives,
- polyphenols such as flavonoids, for example isoflavonoids, quercetin, stylbens, for example resveratrol, catechins, for example epicatechine-3-gallate, epigallocatechine-3-gallate,
- Perfumery components such as vanillin, indol, or more generally essential oils such as citrus, lavender, essential oils.
- liposoluble pharmaceutical active principles for example Fluvastatin, Ketoprofen, Verapamil, Atenolol, Griseofulvin, Ranitidine.
- hydrophilic active principles may be chosen from aminoglucosides (gentamicin), antibiotics ( ⁇ -lactam, sulbenicillin, cefotiam, cefmenoxime), peptide hormones (TRH, leuprolide, insulin), antiallergic, antimycotic, cytostatic or diagnosis, anxiolytics, contraceptives, sedatives, mineral salts (calcium, chlorine, magnesium, phosphorus, potassium, sodium, sulfur), trace elements (aluminum, bromine, copper, cobalt, iron, fluorine, manganese, molybdenum, iodine , selenium, silicon, vanadium, zinc), amino acids (alanine, arginine, asparagine, aspartic acid, cysteine, glutamic acid, glutamine, glycine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, praline, serine, threonine, tryp
- the textiles may be non-woven, woven or knitted textiles. They consist of natural or synthetic fibers alone or mixed. Natural fibers are selected from cotton, wool, silk and / or jute.
- the synthetic fibers are chosen from polyamides, polyesters, polyacryl nitrites, polyolefins such as polypropylene or polyethylene or Teflon.
- the fibers can be spun, carded or twisted.
- the fibers may have been treated with the treatment method according to the invention for the manufacture of a textile, or the textile has been treated with the method according to the invention.
- textiles treated according to the method according to the invention can be used for the manufacture of clothing, gloves, footwear, underwear, stockings, tights, as well as medical articles such as bandages, splints dressings, compresses, bandages, masks.
- the textiles used in the context of the present invention which are thus impregnated with at least one active ingredient, are resistant to washing, it is possible to cover the fibers of which said textiles are made of a thin film, acting as a protective sheath and covering the nanoparticles of active ingredients.
- This sheath will disintegrate gradually in contact with the subject wearing the textile, as well as during the various washes, which will allow the release, spaced in time, at least one active ingredient on and / or in the skin that is found between the textile fibers and surrounded by this sheath.
- the amount of nanoparticles used is between 10 and 50 g of nanoparticles per kg of fibers and / or textiles.
- the impregnation of the textile and / or fibers can be carried out by dipping and / or spraying. In one embodiment of the present invention, the impregnation is carried out by dipping at a temperature of between 20 and 60 ° C.
- the aqueous solution may comprise other additives chosen from preservatives, antibacterials, fillers, defoamers, antistatic agents, stabilizers and antioxidants.
- the aqueous solution may also include fireproofing agents, plasticizers, pigments, as well as those which will allow the formation of a protective sheath around the fibers of which the textile is made.
- the impregnation protocol may be the following.
- the impregnation is carried out on fibers and / or a dried textile, after possibly an enzyme treatment.
- the weight of particles used is 20 g per kg of fiber and / or textile.
- the bath used comprises 1 kg of fibers and / or textile for 20 liters of water.
- the pH of the water is between 5.5 and 7.5.
- the fibers and / or the textile are added to the water optionally containing other additives which have been mentioned above.
- the temperature of the assembly is raised to around 40 ° C.
- the nanoparticles are added to the mixture in one or more times.
- the fixation of the particles can be observed by decreasing the turbidity of the aqueous medium.
- the mixture is left stirring for about 30 minutes. After emptying, the fibers and / or the textile are dewatered and dried at a temperature below 50 ° C.
- the treatment method according to the present invention can be carried out on a textile that has been washed and / or brought into contact with the skin, and therefore for which the at least one active ingredient has been salted out.
- the object is to re-impregnate the textile, which can be achieved by spraying the textile of the at least one active principle. Spraying can be carried out using an aqueous solution containing said at least one active principle.
- This spray has the further advantage that it can be targeted to particular areas of the textile that are in contact with the parts of the body on which the at least active ingredient must act in a preferred manner. To illustrate this, one can cite the example of underwear or footwear for which only certain parts of the textile will be treated.
- a use of the textile treatment method according to the present invention may consist in controlling and / or following the release onto and / or in the skin of the at least one active principle by means of a textile control label. which has been impregnated with dye nanoparticles.
- the amount of dye nanoparticles must be adjusted in such a way that the discoloration of the control label is proportional to the release of the at least one active principle from which the textile is impregnated. It is thus possible to evaluate the quantity of the at least one active ingredient salted out by the visualization of the discoloration of the control label.
- a new label which may be provided with the container of the refill emulsion, or which is produced directly by the user, and this by spraying with the aid of a control emulsion which will comprise therefore the dye nanoparticles.
- This method of control and / or monitoring has the advantage of avoiding unwanted reloads that can be dangerous and result in overdoses of active ingredient. Also, this makes it possible to precisely follow the exhaustion curve which depends on the conditions of exposure and / or wearing of the textile, as well as the washing conditions.
- the following examples illustrate the invention without limiting its scope.
- Example 1 Impregnation of a textile (polyamide 93%, elastane 7%) with menthol nanoparticles.
- the amount of menthol used was 2 g per 100 g of nanoparticles.
- the amount of nanoparticles was 5 g per 100 g of textile to impregnate said textile.
- the nanoemulsion was diluted in water and stirred.
- the amount of water was adjusted to have 2OL of water for 1 kg of textile.
- the impregnation time was 30 minutes, and after spinning the fabric was dried under air flow at 40 ° C.
- the purpose was to determine the amount of encapsulated dye remaining on a cloth fabric after 20 washes.
- the textiles used were white fabric fabrics.
- the dye used was a white solid which dissolved gives a pink solution.
- the CAS number is: 13473-26-2.
- the dye was in the form of a nanoemulsion obtained according to the process described in WO2004 / 060358 A2.
- the assay technique used was UV spectrophotometry.
- the impregnation of the fabric was carried out as follows:
- the dipping and impregnation baths were prepared as follows: In an Erlenmeyer flask were diluted 11 ml of the aforementioned dye nanoparticle emulsion in 33 ml of distilled water (temperature 20.5 ° C.).
- the pieces for 10, 20 and 30 minutes of soaking were gently coated in the first bath; the other rooms in the second bath.
- the soaking time was counted from the moment the piece was in contact with the dye solution in the form of a nanoemulsion.
- the two pieces of tissue (the control and the one for washing) were removed from the bath using a pair of pliers. They were drained on the edge of the crystallizer and were then dried in an oven under a stream of hot air whose temperature was 60 0 C, and yet 20 min (the drying was checked to the touch: if the fabric was not completely dry, it was put back to drying 10 minutes more).
- the aim was to extract from the tissues the dye remaining still impregnated in the tissues.
- pieces of tissue of about 5x5 mm were scissors cut in different parts of the fabric, and were weighed and put in a microwave reactor with a magnetic stirrer.
- the maximum power was 100 W
- the temperature was fixed at 100 0 C
- the heating time was 5 minutes (the time to reach the desired temperature was not counted, but it was of the order of 2
- a sample of the obtained solutions was introduced into a quartz UV tank and the OD was measured at 549 nm.
- the samples were weighed on a precise scale at mg.
- the scale used was accurate to the tenth of a mg.
- the scale used was accurate to the tenth of a mg.
Landscapes
- Engineering & Computer Science (AREA)
- Textile Engineering (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Theoretical Computer Science (AREA)
- Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Dispersion Chemistry (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Chemical Or Physical Treatment Of Fibers (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0609999A FR2908427B1 (fr) | 2006-11-15 | 2006-11-15 | Procede d'impregnation de fibres et/ou de textiles par un compose d'interet et/ou un principe actif sous forme de nanoparticules |
| PCT/FR2007/001878 WO2008068418A2 (fr) | 2006-11-15 | 2007-11-15 | Procédé de traitement d'un textile et/ou de fibres par un principe actif sous forme de nanoparticules |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP2097572A2 true EP2097572A2 (de) | 2009-09-09 |
Family
ID=38511361
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP07870284A Active EP2106470B1 (de) | 2006-11-15 | 2007-11-15 | Steuerungs- und oder überwachungsverfahren für die entsalzung mindestens eines in einen textilstoff imprägnierten wirkstoffs |
| EP07870285A Withdrawn EP2097572A2 (de) | 2006-11-15 | 2007-11-15 | Textilien- und/oder faserverarbeitungsverfahren unter verwendung eines aus nanopartikeln zusammengesetzten wirkstoff-bestandteils |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP07870284A Active EP2106470B1 (de) | 2006-11-15 | 2007-11-15 | Steuerungs- und oder überwachungsverfahren für die entsalzung mindestens eines in einen textilstoff imprägnierten wirkstoffs |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20100058973A1 (de) |
| EP (2) | EP2106470B1 (de) |
| CN (1) | CN101558195A (de) |
| AT (1) | ATE524591T1 (de) |
| FR (1) | FR2908427B1 (de) |
| WO (2) | WO2008068417A2 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9861154B2 (en) | 2008-07-18 | 2018-01-09 | Biomod Collection Inc. | Articles of manufacture releasing an active ingredient |
| FR2941972B1 (fr) * | 2009-02-09 | 2011-05-27 | Ab7 Ind | Procede d'enduction de microspheres sur un materiau souple |
| FR2971437B1 (fr) * | 2011-02-10 | 2013-02-15 | Alpol Cosmetique | Nouvelles microparticules cationiques et utilisation dans le domaine des cosmetotextiles |
| FR2973046B1 (fr) * | 2011-03-25 | 2015-07-17 | Sophie Beauge-Duguet | Article textile impregne de compose d’interet et de compose photoluminescent et procede de controle et/ou de suivi du relargage du compose d’interet |
| CN104740893B (zh) * | 2015-02-28 | 2016-09-21 | 湖北中烟工业有限责任公司 | 一种超声辅助加速溶剂萃取香荚兰酊剂的方法 |
| EP3703668A1 (de) * | 2017-11-01 | 2020-09-09 | Clexio Biosciences Ltd. | Fertige faserstrukturen und verfahren zu deren verwendung und herstellung |
| ES2784955B2 (es) * | 2019-03-29 | 2021-06-17 | Nayco Man S L | Marcador del grado de liberacion de elementos dificil o lentamente biogregadable (elementos nocivos) al medio ambiente para objetos |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2926097A (en) * | 1944-11-03 | 1960-02-23 | Leatherman Martin | Fire resistant composition for fabrics |
| US3547688A (en) * | 1967-01-04 | 1970-12-15 | Gagliardi Research Corp | Microbiocidal complexes of aziridinyl compounds and biocidal metal salts and their use in rendering textiles or other substrates durably microbiocidal |
| CH672512A5 (de) * | 1984-12-08 | 1989-11-30 | Albert Kamber | |
| US5293648A (en) * | 1991-10-28 | 1994-03-15 | Galey & Lord, Incorporated | Tag for visually indicating loss of a protective agent |
| FR2783959B1 (fr) * | 1998-09-25 | 2001-11-16 | Start | Etiquette temoin d'entretien pour articles textiles |
| AU7136000A (en) * | 1999-07-19 | 2001-02-05 | Avantgarb, Llc | Nanoparticle-based permanent treatments for textiles |
| DE60034368T2 (de) * | 1999-12-28 | 2008-01-03 | Kimberly-Clark Worldwide, Inc., Neenah | Verwendungs-abhängiges indikatorsystem für absorbierende artikel |
| CH695946A5 (de) * | 2000-04-04 | 2006-10-31 | Schoeller Technologies Ag | Ausrüstung von textilen Fasern, Geweben und Flächengebilden. |
| EP1243688A1 (de) * | 2001-03-22 | 2002-09-25 | Cognis Iberia, S.L. | Verwendung von Chitosan-Nanopartikeln |
| WO2003029811A1 (en) * | 2001-10-04 | 2003-04-10 | Digieye Plc. | Assessing colour fastiness |
| US7048771B2 (en) * | 2001-10-22 | 2006-05-23 | University Of California | Dyeing textiles using nanoparticles |
| FR2838459B1 (fr) * | 2002-04-12 | 2004-10-01 | Pierre Combe | Matieres textiles impregnees et leur procede de realisation |
| DK1359247T3 (da) * | 2002-04-30 | 2006-02-13 | Cognis Ip Man Gmbh | Med mikrokapsler behandlede fibre og flade tekstilprodukter |
| DE602004016022D1 (de) * | 2003-10-30 | 2008-10-02 | Mcneil Ppc Inc | Zusammengesetzte materialien aus metall beladenen abgeblätterten nanoteilchen |
| DE10356095A1 (de) * | 2003-11-27 | 2005-06-30 | Deutsches Textilforschungszentrum Nord-West E.V. | Cyclodextrin als Verankerungschemikalie zur Ausrüstung von textilem Material |
| TW200615424A (en) * | 2004-07-20 | 2006-05-16 | Schoeller Textil Ag | Finishings for textile fibres and babrics to give hydrophobic oleophobic and self-cleaning surfaces |
| DE102004037752A1 (de) * | 2004-08-04 | 2006-03-16 | Cognis Deutschland Gmbh & Co. Kg | Ausgerüstete Fasern und textile Flächengebilde |
| WO2006049479A1 (en) * | 2004-11-08 | 2006-05-11 | Bio Dreams Co. Ltd. | Antimicrobial spray compositions |
-
2006
- 2006-11-15 FR FR0609999A patent/FR2908427B1/fr not_active Expired - Fee Related
-
2007
- 2007-11-15 EP EP07870284A patent/EP2106470B1/de active Active
- 2007-11-15 WO PCT/FR2007/001877 patent/WO2008068417A2/fr not_active Ceased
- 2007-11-15 WO PCT/FR2007/001878 patent/WO2008068418A2/fr not_active Ceased
- 2007-11-15 AT AT07870284T patent/ATE524591T1/de not_active IP Right Cessation
- 2007-11-15 CN CNA2007800421865A patent/CN101558195A/zh active Pending
- 2007-11-15 US US12/514,333 patent/US20100058973A1/en not_active Abandoned
- 2007-11-15 EP EP07870285A patent/EP2097572A2/de not_active Withdrawn
Non-Patent Citations (1)
| Title |
|---|
| See references of WO2008068418A2 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2106470B1 (de) | 2011-09-14 |
| EP2106470A2 (de) | 2009-10-07 |
| WO2008068418A3 (fr) | 2008-07-24 |
| FR2908427A1 (fr) | 2008-05-16 |
| FR2908427B1 (fr) | 2009-12-25 |
| CN101558195A (zh) | 2009-10-14 |
| WO2008068417A2 (fr) | 2008-06-12 |
| WO2008068417A3 (fr) | 2008-07-24 |
| US20100058973A1 (en) | 2010-03-11 |
| WO2008068418A2 (fr) | 2008-06-12 |
| ATE524591T1 (de) | 2011-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2097572A2 (de) | Textilien- und/oder faserverarbeitungsverfahren unter verwendung eines aus nanopartikeln zusammengesetzten wirkstoff-bestandteils | |
| Ta et al. | Chitosan nanoparticles for enhancing drugs and cosmetic components penetration through the skin | |
| CN104822366B (zh) | 在丝纤蛋白生物材料中香料和/或调味剂的包封 | |
| KR102219776B1 (ko) | 생체 광자성 조성물들, 키트들 및 방법들 | |
| US11737955B2 (en) | Multi-functional micro and nanoparticles for use in root canal therapies | |
| Singh et al. | Photodynamic therapy: An adjunct to conventional root canal disinfection strategies | |
| FR2718018A1 (fr) | Composition cosmétique et/ou dermatologique à support hydrophile et vitamine C mélangeables extemporanément. | |
| WO1993005753A1 (fr) | Composition pour un traitement cosmetique et/ou pharmaceutique de longue duree des couches superieures de l'epiderme par une application topique sur la peau | |
| CN105473160A (zh) | 治疗不愈合伤口的组合物和方法 | |
| Chen et al. | Nonporous versus mesoporous bioinspired polydopamine nanoparticles for skin drug delivery | |
| FR3002745A1 (fr) | Particules de type cœur-ecorce a base de polydopamine et d'huile vegetale | |
| FR2653334A1 (fr) | Preparation cosmetique de bronzage. | |
| FR2996466A1 (fr) | Procede d'encapsulation par coacervation ne mettant pas en œuvre de reticulant toxique | |
| EP4247538A1 (de) | Verfahren zur herstellung von biologisch abbaubaren mikrokapseln und verwendung der hergestellten mikrokapseln | |
| FR2999613A1 (fr) | Materiau textile impregne de principes actifs et comprenant des particules de ceramique | |
| JP2021518346A (ja) | 緩衝化マイクロカプセル化組成物および方法 | |
| WO2000005446A1 (fr) | Article textile ou vestimentaire ou de toilette et soin du corps, porteur de microcapsules, et procedes pour sa realisation | |
| KR20170009377A (ko) | 피부 분산력이 우수한 녹는 제형의 피부접촉용 섬유시트 및 그를 이용한 제품 | |
| FR2897533A1 (fr) | Agent oxydant pour le traitement des cheveux | |
| WO2013175289A2 (fr) | Utilisation d'une composition contenant un polymère et des charges minérales pour lutter contre le vieillissement cutané | |
| FR2734477A1 (fr) | Composition destinee a stopper la chute et/ou a favoriser la repousse des phaneres | |
| JP2719440B2 (ja) | 繊維品類の処理方法 | |
| FR2973046A1 (fr) | Article textile impregne de compose d’interet et de compose photoluminescent et procede de controle et/ou de suivi du relargage du compose d’interet | |
| FR3073413B1 (fr) | Composition parfumante utilisee en aromaparfumerie® | |
| EP2673413B1 (de) | Kationischen mikroteilchen und verwendung auf dem gebiet der kosmetischen textilien |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20090609 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR |
|
| 17Q | First examination report despatched |
Effective date: 20091112 |
|
| DAX | Request for extension of the european patent (deleted) | ||
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20120313 |